Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
05/12/2010 | CN101703545A Ginkgo American ginseng saponin capsule and preparation method thereof |
05/12/2010 | CN101703544A Pellet of acanthopanax senticosus extract and preparation method thereof |
05/12/2010 | CN101703524A Quality control method for leech and preparation containing leech |
05/12/2010 | CN101703519A Method for improving hemostatic effect of external-use zeolite hemostat by calcium ion modification |
05/12/2010 | CN101703513A Compound sustained-release preparation of aspirin and clopidogrel or pharmaceutically acceptable salt thereof |
05/12/2010 | CN101703497A Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries |
05/12/2010 | CN101703493A Electrospinning composite nanofiber membrane of medicament ferulic acid, preparation method and application thereof |
05/12/2010 | CN101703475A Chondroitin sulfate pellet and preparation method thereof |
05/12/2010 | CN101703240A Plasmin carrier lipidosome for promoting absorption of intestine and preparation method thereof |
05/12/2010 | CN101703178A Method for removing gingkolic acid from gingkgo by adopting food engineering technology |
05/12/2010 | CN101342267B Donkey-hide gelatin angelica polymorpha & hoantchy particle and method of preparing the same |
05/12/2010 | CN101190915B Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application |
05/12/2010 | CN101190297B Traditional Chinese medicine compound preparations for preventing and controlling abnormal uterine bleeding after medical abortion |
05/12/2010 | CN101073597B Medicinal composition for contracting uterus, stopping blood and regulating emmenia and its production method |
05/12/2010 | CN101072506B Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use |
05/12/2010 | CN101062086B Composite medicine for reducing blood fat and dissolving thrombus and its preparing process |
05/12/2010 | CN101049356B Pharmaceutical composition of containing puerarin and leaves of hawthorn |
05/12/2010 | CN101032512B Medicine composition for expanding blood volume and the preparing method thereof |
05/12/2010 | CN101011421B Pollen tablet and its preparing process |
05/12/2010 | CN100998638B Traditional Chinese medicine for nourishing liver and kidney, nourishing blood and invigorating the circulation of blood |
05/12/2010 | CN100998617B Quality control method for Xindakang preparation |
05/11/2010 | US7713999 Thrombin receptor antagonists |
05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
05/11/2010 | US7713721 Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
05/11/2010 | US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
05/11/2010 | CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
05/11/2010 | CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
05/11/2010 | CA2410177C Thrombin receptor antagonists |
05/11/2010 | CA2381205C Method for determining physiological effects of hemoglobin |
05/11/2010 | CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
05/06/2010 | WO2010050787A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
05/06/2010 | WO2010050525A1 Compound having tafia inhibitory activity |
05/06/2010 | WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
05/06/2010 | WO2010049709A2 Therapeutic compositions |
05/06/2010 | WO2010049705A2 Therapeutic compositions |
05/06/2010 | US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo) |
05/06/2010 | US20100113506 Composition for preventing or treating thrombus- or embolus- associated disease |
05/06/2010 | US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants |
05/06/2010 | US20100113444 Prolyl hydroxylase inhibitors |
05/06/2010 | US20100113393 Boronic Acid Salts |
05/06/2010 | US20100113391 Bicyclic heterocyclic compound |
05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
05/06/2010 | US20100113365 Factor viii polymer conjugates |
05/06/2010 | US20100113364 Factor viii polymer conjugates |
05/06/2010 | US20100113360 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
05/06/2010 | US20100113353 Method and composition for inhibiting cardiovascular cell proliferation |
05/06/2010 | US20100113345 Preparation of low bleeding anticoagulant fusion protein and its use |
05/06/2010 | US20100113339 Serum albumin binding proteins with long half-lives |
05/06/2010 | US20100111946 Inhibiting activation with human anti-factor c3 antibodies and use thereof |
05/06/2010 | US20100111910 Treatment of excessive neovascularization |
05/06/2010 | US20100111898 Conjoint therapy for treating fibrotic diseases |
05/06/2010 | CA2741783A1 Compounds having tafia inhibitory activity |
05/05/2010 | EP2181731A1 Organic compounds with biological effect as thrombin inhibitor and use of same |
05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
05/05/2010 | EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
05/05/2010 | CN1981853B Chinese-medicinal decoction for treating heart disease and cerebral thrombosis and its making method |
05/05/2010 | CN1981840B Chinese-medicinal composition with anti-inflammatory and hemostasis functions and its production |
05/05/2010 | CN1964729B Composition for prevention and treatment of urinary incontinence |
05/05/2010 | CN1961912B Chinese medicinal composition having pain-easing bleeding-stopping functions |
05/05/2010 | CN1954812B Use of Edaravone |
05/05/2010 | CN1911219B Medicine composition, and its application |
05/05/2010 | CN1883493B Solid-state molecular dispersible preparation of pennogenin compound |
05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
05/05/2010 | CN1682707B Pharmaceutical composition comprising fenofibrate and process for its preparation |
05/05/2010 | CN1665496B Use of EPA and DHA in Preparation of medicinie for secondary prevention of neurogenic diseases |
05/05/2010 | CN1642574B Remedies for glomerular diseases |
05/05/2010 | CN101701020A Amide derivate, preparation method and application thereof |
05/05/2010 | CN101700364A Thrombolytic and lipid-lowering pill |
05/05/2010 | CN101700341A Biological composition for nourishing kidney and protecting liver and preparation method for oral liquid thereof |
05/05/2010 | CN101700326A Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria |
05/05/2010 | CN101700285A Application of rumex japonicus in preparing medicines |
05/05/2010 | CN101700267A Detection method of persimmon leaf quality |
05/05/2010 | CN101700251A Donkey-hide gelatin soft capsule |
05/05/2010 | CN101700248A Preparation method of Aspirin and Captopril enteric sustained-release capsule |
05/05/2010 | CN101700243A Novel medicine carrying woundplast with treating function |
05/05/2010 | CN101700228A Preparation method of amino polysaccharide Aspirin composite nanometer particles |
05/04/2010 | US7709677 e.g.3-{3-[(2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino]phenyl}isonicotinic acid ; useful as agonists at atypical beta-adrenoceptors; treatment of hyperglycaemia, animal growth promoters, blood platelet aggregation inhibitors, as positive inotropic agents and antiatherosclerotic agent |
05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
05/04/2010 | US7709500 Chemical compounds |
05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
05/04/2010 | US7709463 Methyl O-(2,3,4-tri-O-methyl-6-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- beta -D-glucopyranosyl uronic acid)-(1 --> 4)-O-(2,3,6-tri-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- alpha -L-idopyranosyl uronic acid)-(1 --> )-2,3,6-tri-O-sulfo- alpha -D-glucopyranoside |
05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
05/04/2010 | CA2221568C Metabolic effects of certain glutathione analogs |
04/29/2010 | WO2010047756A1 Oral dosage forms including an antiplatelet agents and an enterically coated acid inhibitor |
04/29/2010 | US20100105896 Pharmaceutical compounds |
04/29/2010 | US20100105757 Treatment and inhibition of disease conditions using flexible heteroarotinoids |
04/29/2010 | US20100105731 Novel benzamidine compound |
04/29/2010 | US20100105712 Chemical compounds |